WU
GPCR icon

Washington University’s Structure Therapeutics GPCR Stock Holding History

Washington University’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,274
Closed -$215K – 8
2023
Q3 		$215K Buy
+4,274
New +$138K 0.08% 9

Other funds holding GPCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Washington University's GPCR Position: Q4 2023 in Review

Washington University sold out of Structure Therapeutics (GPCR) in Q4 2023, closing a stake of 4,274 shares — an estimated $215K sold.

Washington University first reported a position in GPCR in Q3 2023 and held it in 1 quarter. The position peaked at $215K in Q3 2023. 121 funds tracked by Wall St. Rank hold GPCR as of Q4 2023.

  • Washington University reported no remaining Structure Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Washington University sold 4,274 Structure Therapeutics shares in Q4 2023, an estimated $215K.
  • Washington University first reported a position in Structure Therapeutics in Q3 2023 and held it in 1 quarter.
  • Washington University's Structure Therapeutics position peaked at $215K in Q3 2023.
  • 121 funds tracked by Wall St. Rank held Structure Therapeutics as of Q4 2023.

Based on Washington University's 13F filing for Q4 2023, filed 25 Jan 2024.